✦ LIBER ✦

Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFα and rituximab

✍ Scribed by Stefan Vordenbäumen; Eva Neuen-Jacob; Jutta Richter; Matthias Schneider

Publisher: Springer
Year: 2010
Tongue: English
Weight: 188 KB
Volume: 29
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-009-1367-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of type 1 diabetes in a pati

Development of type 1 diabetes in a patient treated with anti-TNF-α therapy for active rheumatoid arthritis

✍ C. J. Tack; F. S. Kleijwegt; P. L. C. M. Van Riel; B. O. Roep 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 80 KB

TNF-alpha blockade induces a reversible

TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis

✍ Silvia Bosello; Angelo Santoliquido; Angelo Zoli; Cristiana Di Campli; Roberto F 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 159 KB

Anti–glomerular basement membrane antibo

Anti–glomerular basement membrane antibody–associated renal failure in a patient with leflunomide-treated rheumatoid arthritis

✍ G. A. W. Bruyn; R. P. Veenstra; C. Halma; J. Grond 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Development of interstitial pneumonia in

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Mineharu Sugimoto 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 326 KB

Anti-TNF-α antibody Infliximab and gluco

Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study

✍ Johannes Strunk; Elisabeth Bundke; Uwe Lange 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 271 KB

Improvement in patient-reported outcomes

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

✍ Keystone, E. ;Burmester, G. R. ;Furie, R. ;Loveless, J. E. ;Emery, P. ;Kremer, J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 2 views